AI-native quality engineering: five questions every UK financial services CTO must answer in 2026
In 2026, the question is no longer whether AI belongs in your quality engineering function. It is whether you are using it deliberately — or whether it is using you.
I have spent the last eighteen months watching UK financial services firms navigate the same transition in different ways. Some have made deliberate investments: they have assessed their readiness, chosen their tooling with intent, built governance frameworks, and can already show meaningful productivity and coverage gains. Others have arrived at the same point through accumulated tool adoption — engineers using AI assistants here, a vendor integrating AI features there — with no coherent picture of what the function now looks like or what it is producing.
Both paths lead to the same place eventually: a quality engineering function in which AI is doing meaningful work. The difference is whether that work is visible, governed, and aligned to the outcomes your firm actually needs — including the outcomes your regulators are increasingly interested in.
This article is not a technology survey. It is a readiness assessment in five questions. If you can answer all five with confidence and evidence, your firm's AI-native QE posture is strong. If some of them reveal gaps, those gaps are worth understanding before they surface somewhere less convenient.
What AI-native QE actually means:
AI-native quality engineering is not the same as using AI tools in QA. It is a systematic approach in which AI augments the entire quality engineering workflow — from requirement analysis and test design through execution, defect triage, coverage analysis, and risk-based prioritisation — within a governed framework that makes its contribution measurable and its outputs defensible. Tool adoption is the starting point. AI-native QE is the operating model that makes tool adoption strategic.
Question 1 — Can you see what AI is doing inside your QA function right now?
This is the foundational question, and it is the one most firms cannot answer with confidence. Not because AI is not present — it almost certainly is — but because its presence has been organic rather than designed. A test engineer using GitHub Copilot to generate test scripts. A QA lead asking an LLM to summarise a defect report. A test automation vendor whose latest release includes AI-powered test maintenance. Each of these is a form of AI entering your quality function. None of them, individually, constitutes a strategy.
The visibility question has two dimensions. The first is inventory: do you know which AI tools are in use, by whom, in which parts of the QA workflow? The second is governance: do you have a framework for assessing, approving, and monitoring AI tool usage that reflects your firm's data handling obligations, your model risk appetite, and your regulatory environment?
In UK financial services, the governance dimension is not optional. The FCA's emerging expectations around AI use in regulated activities, the PRA's model risk management supervisory statement, and the cross-regulatory AI and Data Ethics framework all carry implications for how AI-generated outputs — including test artefacts, defect analyses, and coverage reports — are produced, reviewed, and relied upon. A quality function that uses AI without governance is building regulatory exposure it does not yet know it has.
The practical check:
Ask your QA team lead to list every AI tool currently in use across the QA function, including free or personal accounts. If this takes more than 24 hours to produce, or if the list is incomplete, your AI governance posture has a gap that predates any strategic AI adoption decision.
Question 2 — Is your AI tooling integrated into your quality framework, or running alongside it?
There is a meaningful distinction between AI tools that are integrated into a firm's quality engineering framework and AI tools that run alongside it. The difference is not technical — it is structural.
Integrated AI means that the outputs of AI tooling — generated test cases, triage recommendations, coverage analysis, risk scoring — feed into the governed quality process. They are reviewed, validated, and recorded as part of the standard workflow. They contribute to the quality evidence that supports release decisions and, where relevant, regulatory reporting.
AI running alongside the framework means that individual engineers use AI tools to make their own work faster or easier, but those outputs exist outside the governed process. They may improve individual productivity. They do not improve the quality function's governance posture, its evidence trail, or its ability to demonstrate control.
The majority of UK FS quality functions currently sit in the second category. This is not a criticism — it is the natural early stage of any technology adoption curve. The question worth asking is whether your firm has a plan to move from the second category to the first, and what that plan looks like.
Question 3 — Can you measure what AI is contributing to your quality outcomes?
Measurement is where AI-native QE separates from AI tool adoption. If you cannot measure the contribution of AI to your quality outcomes — coverage, defect detection rate, testing cycle time, regulatory evidence quality — you cannot manage it, improve it, or defend it to a board or regulator.
The measurement framework for AI-native QE in a financial services context covers four dimensions:
Coverage contribution: what proportion of your test coverage is AI-generated, AI-maintained, or AI-prioritised? Is that proportion growing, stable, or decaying as the codebase changes?
Defect detection quality: are AI-generated test cases catching the same class of defects as human-authored cases, or are they concentrating on high-frequency, low-risk paths? The answer to this question determines whether AI is covering your critical risk surfaces or optimising for volume.
Cycle time impact: has AI tooling materially shortened your testing cycles? If yes, is that saving being reinvested in higher-value testing activity, or absorbed as headcount reduction? Only the first of these represents a quality gain.
Regulatory defensibility: can the testing evidence produced with AI assistance be presented to a regulator as a credible, reproducible account of the testing conducted? Or does its AI provenance introduce questions about the reliability or independence of the outputs?
If your current measurement framework does not track these four dimensions, your firm is using AI in its quality function without a meaningful ability to assess whether the investment is working.
Question 4 — Is your team's capability keeping pace with the tooling?
One of the least-discussed risks in AI-native QE adoption is the capability gap that opens when tooling moves faster than the team's ability to use it well. In financial services, this risk is more acute than in most sectors, because the consequence of poor AI use in a quality function is not just a suboptimal test suite — it is a quality function that is producing outputs it cannot fully verify, in a regulatory environment that is increasingly interested in how those outputs were produced.
The specific capability questions that matter for a UK FS quality function are:
Prompt engineering for test design: can your QA engineers write effective prompts that produce accurate, risk-aligned test cases for complex financial services business logic — not just syntactically correct test scripts?
AI output validation: does your team have the domain knowledge and quality discipline to review AI-generated artefacts critically, rather than accepting them at face value? This is the human judgement layer that makes AI-native QE defensible.
Model risk awareness: do your senior QA engineers and architects understand the failure modes of the AI tools they are using — including hallucination, distribution shift, and training data limitations — and know how to design their processes to mitigate them?
Regulatory translation: can your quality leadership team articulate the firm's AI-native QE approach in language that satisfies FCA, PRA, or board-level scrutiny?
Capability gaps in any of these areas are not a reason to slow AI adoption. They are a reason to design the adoption programme around them.
Question 5 — Does your board know what your AI-native QE posture actually is?
This is the question that most technology leaders leave until last, and the one that is becoming most pressing most quickly. The UK regulatory environment in 2026 expects boards of regulated firms to have oversight of material technology risks, and AI use in operational and quality functions is increasingly within scope of that expectation.
The three board-level questions that matter most are straightforward. They are also the questions that reveal whether an organisation has a genuine AI-native QE posture or a collection of individually adopted tools.
What AI tooling is in use across our quality engineering function, and what governance framework applies to it?
What proportion of our testing artefacts are AI-generated or AI-assisted, and how is the quality of those artefacts assured?
How does our AI use in quality engineering affect our ability to produce defensible evidence for regulatory purposes?
If your technology leadership team cannot answer these three questions with clarity and evidence, the gap is not primarily a technology problem. It is a governance and measurement problem — and those are solvable, with the right framework.
What the maturity levels actually look like
Within the RegalTech QA Maturity Framework, AI-Native Quality Engineering is assessed as Dimension 7 across five levels. The progression is not about tool adoption — it is about the integration of AI into a governed quality function that produces measurable, defensible outcomes.
Level | Label | What it looks like in practise |
Level 1 | Unmanaged adoption | Individual engineers using personal AI tools with no firm-level visibility, governance, or measurement. |
Level 2 | Emerging awareness | Firm is aware of AI tool use. Some informal guidelines in place. AI outputs not integrated into governed QA process. No measurement framework. |
Level 3 | Structured integration | AI tooling formally assessed and approved. Outputs integrated into quality workflow. Basic measurement in place. Team capability development underway. |
Level 4 | AI Native operation | AI embedded across the QE workflow with full governance. Contribution measured quarterly. Regulatory defensibility demonstrated. Board-level visibility maintained. |
Level 5 | Competitive differentiation | AI-native QE is a measurable business advantage. AI contributes to risk-based coverage decisions, regulatory evidence quality, and delivery speed in ways competitors cannot match. |
Most UK regulated mid-market firms currently sit at Level 1 or Level 2 on this dimension. A small number have reached Level 3. Level 4 is achievable within 12 months with a structured programme. Level 5 is where competitive advantage begins.
The natural next step
The five questions in this article are a diagnostic lens. They are designed to reveal the shape of your firm's AI-native QE posture — not as a score, but as a conversation starter with your technology leadership team and, where relevant, your board.
If the questions have surfaced genuine gaps, the right next step is a structured baseline assessment. The RegalTech QA Maturity Framework includes Dimension 7 in full — with the complete five-level descriptor set, the diagnostic statements, and the risk exposure read for each maturity band. It is free to access and takes approximately 45 minutes to complete with two or three senior colleagues.
The questions that generate the most productive internal debate are usually the ones where your team disagrees on the score. Those disagreements are where the real insight lives.
Access the full eight-dimension QA Maturity Framework, including the complete AI-Native QE dimension with maturity descriptors, scoring statements, and a risk exposure read at each level. Takes 45 minutes. Produces a radar profile and a 90-day prioritisation plan.
— Nipun Kumar, Founder & CEO, RegalTech Global Delivery Systems
Comments